Navigation Links
2011 Proves Positive for UBM Live's Portfolio of Indian Pharma Events
Date:3/22/2012

AMSTERDAM, March 22, 2012 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced that its India Pharma portfolio of events had a strong year in 2011. There was a positive growth in attendance figures over last year's Pharma events in Mumbai. Hosted from 30th November to 2nd December, 2011 at the Bombay Exhibition Centre, the line-up featured CPhI India for pharmaceutical ingredients, P-MEC India for pharmaceutical equipment, machinery and technology, ICSE India for contract services, clinical trials, and CROs and the BioPh trail for the biopharma market. Over three days, the events hosted 825 exhibitors from 21 different countries with an attendance of 27,437 people from 96 countries across the globe.

CPhI India and co-located events had top level exhibitor attendance from key industry companies such as BASF India, Lupin, Piramal Healthcare, Merck, SGS Life Science, and Aurobindo Pharma in 2011. The events were run in a traditional exhibition format with a complementary programme of networking and educational events run daily. New features included an exhibition tent in the parking area that acted as an extension of the venue and hosted over 100 new exhibitors. Returning features included the second year of the Conference Sessions which had strong attendance and covered hot industry topics such as Global Clinical Trials; Global Biosimilars Regulations; Healthcare and OTC Drugs; Developing Difficult Generics; Export Potential; and Competitive API Strategies. 

The Indian pharma market offers a unique business environment due to various factors including low cost of R&D and production, cutting edge technologies, and a well-educated and innovative work force. As the Indian pharma market grows, a focus is being placed on expansion through strategic investments and partnerships globally. Echoing this focus, CPhI India and co-located events were inaugurated by Martin O'Malley, Governor of Maryland, who came to Mumbai with a full delegation and plans to discuss how the Indian Government and Maryland can partner to support the pharma industry in Maryland.

"Our events have grown with this market organically. Especially over the past five years, we have seen India become the fourth largest pharma market globally and it is exciting to see the progress," noted Greg Kerwin, UBM Pharma Portfolio Director. He continued, "We are pleased to see that our customer base continues to grow and has positive feedback about the impact that the India pharma events have on their business. We work very hard to ensure that the events facilitate maximum exposure across the various sectors of the Indian Pharma market."

New exhibitor, Technoflex, confirmed that they saw immediate results from the event. Sylvie Ponlot, Communication Manager for the company commented, "This was our first CPhI India in Mumbai. We made contact with many new prospective clients and several customers. We strongly believe that new projects will result from our attendance. This was a really fruitful show for Technoflex and we will definitely be in Mumbai next year."

CPhI India, ICSE and P-MEC India will return to the Bombay Exhibition Centre in Mumbai from 21-23 November 2012. To learn more about CPhI India, please visit: http://www.cphi-india.com/home

UBM's market leading schedule of annual pharma events also includes Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Centre, Japan), South East Asia (10-12 May, 2012, Jakarta International Expo, Indonesia), ICSE USA (22-23 May, 2012, Pennsylvania Convention Centre, Philadelphia), China (26-28 June, 2012, SNIEC, Shanghai, China), South America (21-23 August, 2012, Transamerica Expo Centre, Brazil) and Worldwide (9-11 October, 2012 at the Feria de Madrid, Spain).

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. U.S. FDA Approves First and Only Oral Contraceptive Demonstrated to Treat Heavy Menstrual Bleeding (HMB)
2. FDA Approves Additional Manufacturer of Methoxsalen
3. Axion Healths ReadySet Software Proves Web-Based Electronic Health Records (EHR) Reduce Clinical Errors and Increase Compliance
4. FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen
5. FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery
6. FDA Approves Gleevec For Expanded Use in Patients With Rare Gastrointestinal Cancer
7. FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis
8. ASAM Approves Prescription Drug Policy
9. FDA Approves Picato® (ingenol mebutate) Gel, the First and Only Topical Actinic Keratosis (AK) Therapy With 2 or 3 Consecutive Days of Once-Daily Dosing
10. FDA Approves Shared REMS (Risk Evaluation and Mitigation Strategy) Program for all TIRF (Transmucosal Immediate Release Fentanyl) Pain Treatments
11. FDA Approves EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the Treatment of Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
Breaking Medicine News(10 mins):